Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.
|Articles|September 1, 2010
- Applied Clinical Trials-09-01-2010
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - September 2010, Supplement
Central Labs EastBoston, MA September 20-22, 2010 Inventive Early Phase Trial Design Discordance Between BICR Readers Recording Adverse Events
Advertisement
Articles in this issue
about 16 years ago
Applied Clinical Trials Digital Edition - September 2010about 16 years ago
Applied Clinical Trials Digital Edition - September 2010, Supplementabout 16 years ago
Geriatric Trials Spark Debateabout 16 years ago
CRO act coverabout 16 years ago
Capturing Real World Dataabout 16 years ago
Business and News Update September 2010about 16 years ago
Transactional vs. Strategic Sourcingabout 16 years ago
Direct-to-Patient Enrollment Strategiesabout 16 years ago
Asia-Pac Grows With China Focusabout 16 years ago
Ominous Clouds Over OutsourcingAdvertisement
Related to this article
Paradigm’s Kurt Mussina touches on why he rejects the “site management organization” model in favor of one unified business.
ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.
ProofPilot’s Lauren Briggs touches on why site tech adoption hinges on the first 90 days after rollout, and why tools succeed only when they remove work from a site’s plate rather than adding another login to juggle.
Jennifer Byrne, CEO, Javara touches on why fixing clinical research requires sustained infrastructure investment and workforce development.
Sequoia’s Dan White and Dr. Tom Kreamer touch on why sponsors and CROs should treat a site network as one centralized partnerto speed startup timelines and strengthen execution.
Sequoia Clinical Research’s CEO Dan White and CMO, Dr. Tom Kreamer explain what it takes to merge three site organizations into one network.
Javara CEO Jennifer Byrne talks about the requirements for embedding clinical trials directly into physician practices and why solving the “last mile” of trial participation means building infrastructure at the actual point of care.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
2026 SCRS Global Site Solutions Summit: What Should Sponsors and CROs Change About How They Contract with a Network?
2
2026 SCRS Global Site Solutions Summit: What's a Mistake Sponsors or CROs Make When Rolling Out New Trial Technology?
3
2026 SCRS Global Site Solutions Summit: Should the Industry Rethink What Scale Means?
4
2026 SCRS Global Site Solutions Summit: What's the Biggest Policy Gap Delaying Integrated, Community-Based Research Being the Norm?
5